Skip to main content
TALPHERA, INC. logo

TALPHERA, INC. — Investor Relations & Filings

Ticker · TLPH ISIN · US00444T2096 LEI · 549300U8W781S4RBUE66 US Manufacturing
Filings indexed 840 across all filing types
Latest filing 2025-11-12 Regulatory Filings
Country US United States of America
Listing US TLPH

About TALPHERA, INC.

https://talphera.com/

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies designed for use in medically supervised settings. The company aims to support healthcare providers and optimize patient outcomes. A key product in its development pipeline is Niyad, a lyophilized formulation of nafamostat. The company was formerly known as AcelRx Pharmaceuticals Inc.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings
2025-11-12 English
SCHEDULE 13G Filing
Major Shareholding Notification
2025-11-10 English
S-3 Filing
Registration Form
2025-10-28 English
S-8 Filing
Registration Form
2025-10-28 English
4 Filing
Director's Dealing
2025-10-24 English
4 Filing
Director's Dealing
2025-10-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.